Benchling Launches ISA-88 Compliant Cloud-Native Bioprocess Platform to Enable High-Throughput Process Development

Benchling USA

Overview

Benchling has introduced “Benchling Bioprocess,” a cloud-native platform featuring an ISA-88 compliant data model to enable high-throughput, structured process development. This integrated environment streamlines process design, experiment planning and execution, and data visualization. The platform aims to simplify technology transfer, boost R&D efficiency, and unlock insights through data science and machine learning applications.

In Depth

Key Findings

Benchling has unveiled “Benchling Bioprocess,” a cloud-native platform poised to revolutionize bioprocess development. By incorporating an ISA-88 compliant data model, this platform facilitates high-throughput and highly structured process development. Researchers and engineers can now manage every step, from process design to experiment planning, execution, and data visualization, within a single, unified environment.

Technical/Clinical Details

Benchling Bioprocess standardizes complex bioprocess workflows and ensures the integrity and quality of data generated at each step. The ISA-88 data model decomposes processes into modular procedures, operations, and phases, allowing for consistent data collection and analysis. This structured approach significantly improves experimental reproducibility and shortens development cycles. The platform’s cloud-native architecture facilitates remote access and collaboration, promoting efficient information sharing across multiple sites and teams. The collected data is seamlessly fed into data science and machine learning algorithms, which generate novel insights for process optimization.

Background & Context

Biopharmaceutical development traditionally involves intricate experimental protocols and the management of vast amounts of data, leading to time-consuming and costly challenges. A particularly frequent bottleneck is the technology transfer from research and development to manufacturing, often hampered by data inconsistencies and non-standardized processes. Benchling Bioprocess addresses these issues by embedding data management and process standardization from the outset, streamlining this crucial transition. This is expected to accelerate the market entry of biopharmaceuticals and improve patient access to vital treatments.

Strategic Significance & Outlook

The introduction of “Benchling Bioprocess” further propels digital transformation within the biopharmaceutical industry. The integration of data-driven approaches and machine learning will make future process development more predictive and efficient. This platform is anticipated to be particularly valuable in the development of complex cell and gene therapy products and novel biologics modalities. Ultimately, it will serve as a critical tool for empowering researchers to discover breakthrough therapies more quickly and enhance overall industry innovation capabilities, boosting productivity across the board.

Get our weekly technology intelligence — free

Receive an infographic that lets you judge at a glance whether each field’s analysis report is worth reading.

Subscribe Free — Weekly Tech Intelligence

By subscribing, you’ll receive Troy-Technical’s weekly technology intelligence newsletter.

• Your email and selected fields are used only to deliver the newsletter.
• We never share your information with third parties.
• You can unsubscribe anytime via the link in each email.

See our Privacy Policy for details.

Agree & Continue ▶

Takes about a minute · Unsubscribe anytime